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Exposure of porcine thyroid cells to the phorbol ester 12-0-tetradecanoylphorbol 13-acetate (TPA) leads 
to inhibition of differentiated thyroid function. We investigated whether this effect is mediated via protein 
kinase C activation. TPA, phorbol 12,13_didecanoate and phorbol 12,13_dibutyrate inhibited TSH-stimulat- 
ed iodine organification in porcine thyroid cells by 98, 96 and 45%;, respectively. Non-tumour promoting 
phorbol esters had no effect. The diacylglycerol analogue, sn-1,2-dioctanoylglycerol had similar but quanti- 
tatively less activity than TPA. Dibutyryl CAMP could not reverse any inhibition noted. Under conditions 
that caused significant inhibition of differentiated function, TPA caused translocation of thyroidal protein 
kinase C from the cytosol to its membrane-bound form. These data provide evidence that the mechanism 
of phorbol action on thyroid function in vitro includes activation of protein kinase C. 
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1. INTRODUCTION 
Tumour-promoting phorbol esters, e.g. 12-0- 
tetradecanoylphorbol 13-acetate (TPA), activate 
protein kinase C by causing its translocation from 
the cytosol to an active membrane-bound form 
[ 1,2]. This is because of their structural similarity 
to the endogenous activator, diacylglycerol which 
is produced following turnover of membrane in- 
ositol phosphates [3]. However, TPA has many ef- 
fects [4], not all of which appear mediated by 
protein kinase C activation [5-71. Exposure of 
thyroid cells to TPA leads to inhibition of differen- 
tiated thyroid function [8-lo]. The present studies 
provide evidence that such effects are, at least in 
part, mediated by protein kinase C. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
TPA, phorbol 12,13-dibutyrate (PDBu), phor- 
bol 12,13_didecanoate, &-phorbol 12,13-dideca- 
noate, 4&phorbol, Hl histone type 111s and 
dibutyryl CAMP [(Bu)~ CAMP] were obtained from 
Sigma. sn-I ,2-Dioctanoylglycerol (DOG) was pur- 
chased from Avanti Polar Lipids. [T-~~P]ATP 
(3ooO Ci/mmol) was obtained from New England 
Nuclear. DEAE cellulose (DE52) was from What- 
man. Bovine TSH (Thytropar) was supplied by 
Armour Pharmaceuticals. 
2.2. Methods 
2.2.1. Iodine organification 
TSH-stimulated iodine organification in 
cultured porcine thyroid cells was based on the 
method of Plannels et al. [l l] as modified by 
Ginsberg et al. [12]. Briefly, isolated porcine 
thyroid cells were incubated in serum-free medium 
with a test substance for 40 min at 37°C prior to 
washing and plating in Falcon 3047 multiwell 
plates (lo6 cells per well in 1 ml MEM containing 
10% newborn calf serum). The cells were in- 
cubated with TSH (lo3 ,uU) or (Bu)~ CAMP 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 309 
Volume 206, number 2 FEBS LETTERS October 1986 
(1 mM) in quadruplicate for 18 h. Na’*‘I (2 ,&i) in 
lo-’ M NaI was then added and incubation con- 
tinued for a further 18 h. The cells were then 
washed with 1 ml EBSS, extracted with 0.1 M 
NaOH and protein bound ‘251 determined fol- 
lowing precipitation with trichloroacetic acid. 
2.2.2. Protein kinase C extraction 
The cells were sonicated in 20 mM Tris-Cl, pH 
7.6, containing 2 mM EDTA, 2 mM PMSF, 
0.5 mM EGTA, 0.33 M sucrose, pH 7.6 (Tepes 
buffer), and centrifuged at 115000 x g for 1 h. The 
supernatant was used as the cytosolic fraction and 
the pellet was resuspended in Tepes buffer contain- 
ing 1% NP40. Protein determinations used the 
method of Bradford [13]. 
2.2.3. DE52 chromatography 
A modification of the procedure of Kraft and 
Anderson [2] was employed. DE52 was washed 
and then equilibrated in 20 mM Tris-HCl, pH 7.6, 
0.5 mM EGTA, 1 mM PMSF, 2 mM EDTA (buf- 
fer A). The DE52 was then poured into a small 
plastic column (6.5 x 0.7 cm) and washed with 
2 ml buffer A. Cytosol or particulate extract in 1% 
NP40 from 1 x 10’ cells was applied and 0.1 M 
NaCl in buffer A was used to elute protein from 
the column. Each collected fraction was im- 
mediately assayed for protein kinase C activity. 
2.2.4. Protein kinase C assay 
Protein kinase C was assayed by measuring the 
incorporation of 32P from [y-32P]ATP into Hl 
histone. The standard assay mixture (250 ~1) con- 
tained 20 mM Tris-HCl, pH 7.6, 50,ug histones, 
1OOpM ATP (-50 cpm/pmol), 75 mM Mg 
acetate, 50~1 sample and 5 mM CaC12, 25 pg 
phosphatidylserine and 0.8 pg 1,2-diolein. In the 
negative control samples, the latter 3 reagents were 
omitted and 0.5 mM EGTA was added. After in- 
cubation for 10 min at 3O”C, 30% trichloroacetic 
acid was added to stop the reaction. The protein 
precipitate was collected on a 0.45 pm membrane 
filter (Millipore) and the incorporation of 32P was 
measured by scintillation counting in a Beckman 
LS 6800. Enzymatic activity was expressed as pmol 
32P incorporated into histone/min per mg protein. 
All assays were performed in quadruplicate. 
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2.2.5. Statistical analyses 
All statistical analyses were performed using a 
one-way analysis of variance on the Epistat com- 
puter program. All experiments were performed 
on at least 3 separate occasions and a represen- 
tative experiment of closely-agreeing assays is 
shown. 
3. RESULTS AND DISCUSSION 
The effects of TPA (10-8-10-6 M) on TSH- 
stimulated iodine organification in porcine thyroid 
cells is shown in fig. 1. The non-tumour promoting 
phorbol ester, 4&phorbol had no effect. The 
dramatic inhibition of iodine organification in the 
cells exposed to’ TPA is similar to that noted by 
others in cultured thyroid cells [&lo]. To deter- 
mine if the mechanism of action of TPA could in- 
clude protein kinase C activation, the ability of 
phorbol esters with different protein kinase C ac- 
tivating abilities were studied in a similar manner 
and the results are shown in fig.2. The tumour- 
promoting phorbol esters TPA, phorbol 
12,13-didecanoate and phorbol 12,13_dibutyrate 
inhibited TSH-stimulated iodine organification by 
98, 96 and 45070, respectively. The non-tumour 
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F&l. The effects of TPA and 4&phorbol on TSH- 
stimulated iodine organification (expressed asorganified 
‘*‘I cpm) in cultured porcine thyroid cells. The phorbol 
esters were dissolved in absolute thanol at 2 mM and 
the final concentrations u ed are shown, ** p < 0.001. 
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Fig.2. The effects of various phorbol esters on TSH- 
stimulated iodine organification in cultured porcine 
thyroid cells. All agents were used at a concentration of
10e7 M (final). TPA, 12-0-tetradecanoylphorbol 
13-acetate; 4cYPDD, rky-phorbol 12,13_didecanoate; 
PDBu, phorbol 12,13-dibutyrate; PDD, phorbol 
12,13-didecanoate; * p < 0.005, ** p < 0.001. 
promoting phorbol esters, 4&phorbol and 4~ 
phorbol 12,13_didecanoate had no effect. The ef- 
fects of these phorbol esters to modulate differen- 
tiated thyroid function in vitro correlates with their 
reported abilities to activate protein kinase C [14]. 
The moderate inhibition of iodine organification 
seen with the potent protein kinase C activator 
PDBu likely relates to its less hydrophobic proper- 
ties when compared to TPA. To ensure these ef- 
fects were not due to a unique property of phorbol 
esters, thyroid cells were exposed to the non- 
phorbol diacylglycerol analogue, DOG prior to 
study. The results are shown in fig.3. Although 
significant inhibition was also seen with DOG, this 
agent could not fully mimic TPA action. Similar 
preliminary results with DOG were noted by 
Bachrach et al. [8]. This may represent altered ac- 
cess to the cell or different metabolism of DOG. 
(Bu)z CAMP could not reverse the inhibition noted 
following any protein kinase C activator (not 
shown) implying a post-receptor locus of action 
for these agents. The principal finding of these 
studies is shown in table 1. Under identical condi- 
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Fig.3. The effect of DOG on TSH-stimulated iodine 
organification. DOG was stored at -7O’C as a 
10 mg/ml solution in chloroform. Immediately before 
use, the chloroform was evaporated and SOpg/ml 
solutions were prepared in 1% dimethylsulfoxide 
(DMSO). Control experiments used 1% DMSO, * p < 
0.005, ** p < 0.001. 
Table 1 
Protein kinase C activity in thyroid cell extracts 
(pmol/min per mg protein) 
Treatment 
4&Phorbol TPA P 
Cytosol 
Membrane 
170* 5 53 * 15 p < 0.001 
111 f 28 466 f 55 p < 0.005 
N.S. p < 0.001 
The results are the mean f SE of quadruplicate values. 
Negative controls always showed protein kinase C 
activity of less than 21 pmol/min per mg protein 
tions of TPA exposure that leads to altered TSH- 
stimulated iodine organification, TPA was capable 
of causing significant translocation of protein 
kinase C activity from thyroid cytosol to its active 
membrane-bound form. Although protein kinase 
C has been previously described in bovine thyroid 
[ 15-171, this is the first study to relate protein 
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Volume 206, number 2 FEBS LETTERS October 1986 
kinase C activation to alterations in differentiated 
thyroid function in vitro. How protein kinase C ac- 
tivation leads to changes in thyroidal metabolism is 
the subject of ongoing experiments. In conclusion, 
these studies indicate that phorbol esters modulate 
differentiated thyroid function in vitro propor- 
tionately to their known ability to activate protein 
kinase C. In the thyroid protein kinase C activa- 
tion by TPA occurs in conjunction with alterations 
in differentiated cell function. These data suggest 
that the action of phorbol esters on thyroid func- 
tion in vitro is mediated, at least in part, via pro- 
tein kinase C. 
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